Kalaris Therapeutics (KLRS) Net Equity Issued and Repurchased (2024)

Kalaris Therapeutics' Net Equity Issued and Repurchased history runs 1 years deep, the most recent figure standing at $1.6 million for Q1 2024.

• In Q1 2024, Net Equity Issued and Repurchased changed N/A year-over-year to $1.6 million; the TTM figure through Dec 2024 stood at $1.6 million (changed N/A YoY), while the FY2025 annual figure was $42.0 million, up 2539.85% from the prior year.
• Net Equity Issued and Repurchased for Q1 2024 stood at $1.6 million.
• The five-year high for Net Equity Issued and Repurchased was $1.6 million in Q1 2024, with the low at $1.6 million in Q1 2024.